
Accelerated TMS compresses a course of treatment that traditionally spans six weeks into a handful of days. For patients, that can mean relief in a fraction of the time. For a practice, it is also a genuine competitive differentiator — a way to stand out in a market where most clinics still offer the same six-week protocol on legacy hardware. This guide explains what accelerated TMS is, why it changes the economics and appeal of a program, and how to position it.
Standard TMS delivers one session per day, five days a week, for roughly six weeks. Accelerated TMS delivers multiple sessions per day over a compressed timeframe, so a full therapeutic course can be completed in days rather than weeks. It is made practical by theta-burst stimulation (iTBS), which achieves a comparable therapeutic dose in about three minutes per session instead of the 20–37 minutes older protocols require. Short sessions are what make multiple daily treatments feasible. Ampa's ONE-D protocol is built specifically around this compressed model; it is covered alongside the other protocols in FDA-Cleared TMS Devices Compared.
It solves the biggest patient objection: time. A six-week, daily-visit commitment is the single largest reason candidates decline TMS. Patients with jobs, caregiving duties, or travel constraints often cannot commit to thirty visits over six weeks. A protocol measured in days removes that barrier and opens the treatment to people who would otherwise never start.
It serves patients that standard protocols cannot reach. Beyond convenience, a compressed course matters for patients who need faster relief or who traveled from outside your immediate area. A patient willing to come for a concentrated block of treatment is a patient a six-week schedule would have lost. That expands your addressable population rather than just reshuffling it.
It increases throughput per room. Because each session is minutes long and patients receive several per day, a single device and room can deliver far more treatments than a one-session-per-day model. Higher throughput on the same fixed footprint improves the economics of the program — an advantage that compounds under a fixed-cost lease, where more treatments do not raise your per-session cost.
Most competitors retrofitted it; a purpose-built system runs it better. Many established devices added accelerated protocols onto hardware designed for the standard six-week model. A system engineered around accelerated delivery from the start — compact, fast to set up between sessions, and built for the ONE-D protocol — runs the compressed schedule more smoothly than a retrofitted cart-based system. Being the practice that offers accelerated TMS well is the differentiator.
This is the first question clinicians and patients ask, and it deserves a careful answer. A growing body of research on accelerated and theta-burst protocols supports their efficacy, and some accelerated approaches have reported strong response and remission rates. At the same time, accelerated TMS is a newer and fast-moving area, and results vary by protocol, targeting, and clinic. The honest positioning is that accelerated TMS is a legitimate, evidence-supported option that offers meaningful advantages in speed and access — not a claim that it is universally superior for every patient. Presenting it that way builds more trust with referring clinicians than overselling it. Because efficacy and safety claims require clinical review, treat the specific outcome figures you publish as content your clinical team should verify.
For patients, lead with what they care about: relief in days instead of weeks, short sessions, and the ability to fit treatment around their life. For referring clinicians, lead with access and evidence: accelerated protocols let them offer TMS to patients who could never commit to six weeks, backed by a real and growing evidence base. In both cases, be specific about what your program offers and candid about what is still being studied. A differentiator only works if patients and partners trust the way you describe it.
What is accelerated TMS? A TMS approach that delivers multiple short sessions per day over a compressed timeframe, completing a full course in days rather than the roughly six weeks a standard daily protocol takes. It relies on theta-burst stimulation, which delivers a therapeutic dose in about three minutes per session.
Is accelerated TMS as effective as standard TMS? Research on accelerated and theta-burst protocols is supportive and growing, with some approaches reporting strong response and remission rates, though it remains a newer area where results vary by protocol and clinic. Specific efficacy claims should be verified by your clinical team before publication.
Why would a practice offer accelerated TMS? It removes the six-week time commitment that causes many candidates to decline treatment, reaches patients who need faster relief or travel for care, and increases the number of treatments a single room can deliver — improving both access and program economics.
Does accelerated TMS require a special device? Any iTBS-capable system can deliver short sessions, but systems purpose-built for accelerated protocols — compact, quick to reset between sessions, and designed around a compressed schedule — run the model more efficiently than hardware retrofitted from the standard six-week protocol.